RXRX Recursion Pharmaceuticals, Inc.

RXRX Recursion Pharmaceuticals, Inc.

Healthcare · Biotechnology

Desk view

PassedLOTTERY (pre-commercial): clinical-stage AI drug-discovery platform; the desk's biotech capital-cycle section files it among the 'lottery tickets' (cash-burning, needs ROI proof). Latest 10-Q on file (quarter ended 2026-03-31, unreconciled EDGAR key-financials): revenue $6.5M against an operating loss of $128.5M. Tape: vwap reclaim verified (price +1.0% vs VWAP, 30D +35.4%) but 1Y -26.2% (alpha vs SPY -42.2%), 3Y -35.5%: no durable uptrend to hold. (2026-10-09)
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $3.31 · VWAP $3.96 · -6.5% vs 12m avg buyer

pullback vol: expandinggaps: stablechurn: churning as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Cluster Director + 1 other sold $367K, Oct 7

Coverage

2 watchlists

Watchlists @biotech-capital-cycle@biotech-scan

RXRX Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist RXRX belongs to, members best 30-day change first — RXRX highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@biotech-capital-cycle
View watchlist →
NAUT+239.7% +24.6%1d +57.3%7d QSI+84.5% +21.7%1d +25.0%7d PACB+49.6% +2.4%1d +22.0%7d CRL+24.5% +1.7%1d +15.1%7d FTRE+21.1% -1.2%1d +5.1%7d CERT+19.6% +2.4%1d +10.3%7d AVTR+17.1% +0.8%1d +5.3%7d DNA+16.4% +2.9%1d -2.7%7d ICLR+13.0% -0.1%1d +8.9%7d MTD+11.9% -0.8%1d +3.0%7d RVTY+11.7% +0.9%1d +4.0%7d SEER+9.4% 0.0%1d -3.0%7d MEDP+8.4% +2.3%1d +8.2%7d AGIO+8.2% -0.5%1d +18.1%7d WAT+7.9% -0.4%1d +3.8%7d ILMN+5.5% 0.0%1d +2.6%7d A+4.7% -0.5%1d +0.1%7d IQV+4.3% +0.4%1d +4.7%7d DHR+4.0% +0.3%1d +0.6%7d TMO+1.3% -0.4%1d -2.3%7d RXRX0.0% +3.4%1d +6.6%7d BRKR-3.5% +0.5%1d +5.1%7d XBI-3.6% -1.4%1d +3.6%7d ABCL-4.0% +4.0%1d +0.2%7d RGEN-4.1% -1.0%1d +0.9%7d ALMR-4.5% +3.3%1d +21.4%7d TXG-5.4% +2.6%1d +2.4%7d ABSI-5.8% -2.0%1d +11.3%7d CDXS-7.3% -2.3%1d +3.2%7d QTRX-9.5% +0.7%1d -0.3%7d TEM-11.7% +6.0%1d +4.5%7d TWST-11.7% +3.3%1d +5.4%7d LAB-18.4% -4.7%1d -3.7%7d SDGR-18.6% +5.3%1d +5.3%7d GENB-24.9% -3.0%1d +2.6%7d VKTX-41.4% -5.5%1d -3.1%7d
@biotech-scan
View watchlist →
GRAL+22.1% +4.3%1d +12.5%7d DNA+16.4% +2.9%1d -2.7%7d ISRG+13.6% +1.9%1d +6.0%7d LLY+10.6% -2.5%1d +1.3%7d BIIB+10.2% -1.2%1d +7.8%7d MRNA+9.9% -1.3%1d -8.2%7d AMGN+8.2% -1.8%1d +1.6%7d ABBV+7.8% +0.2%1d +0.1%7d MDT+6.8% -1.2%1d +0.7%7d ILMN+5.5% 0.0%1d +2.6%7d RARE+5.2% -1.9%1d +7.6%7d A+4.7% -0.5%1d +0.1%7d LEGN+4.4% +2.0%1d +4.3%7d IQV+4.3% +0.4%1d +4.7%7d DHR+4.0% +0.3%1d +0.6%7d GILD+3.1% -0.7%1d -0.1%7d NVO+2.3% -1.0%1d +0.6%7d VRTX+1.5% -2.1%1d +4.8%7d TMO+1.3% -0.4%1d -2.3%7d IBB+0.6% -0.9%1d +2.9%7d REGN+0.4% -1.7%1d +1.8%7d RXRX0.0% +3.4%1d +6.6%7d PTGX-0.2% -0.8%1d +7.5%7d COGT-0.6% -0.3%1d +5.7%7d IBBQ-0.7% -1.1%1d +2.4%7d BEAM-1.3% -2.1%1d +2.5%7d IONS-2.3% -2.2%1d 0.0%7d XBI-3.6% -1.4%1d +3.6%7d KYMR-4.1% -0.1%1d +5.7%7d DFTX-5.3% -0.9%1d +11.1%7d SRPT-6.4% -2.5%1d +3.7%7d INCY-7.2% -1.0%1d +2.3%7d NTLA-9.1% +0.5%1d -1.8%7d ALNY-9.1% -1.4%1d -3.4%7d BMRNE-10.1% -1.2%1d +2.3%7d BNTX-10.5% -1.7%1d +0.5%7d EDIT-10.8% -3.6%1d +2.1%7d DXCM-11.2% -0.5%1d -9.4%7d CRSP-11.4% -1.2%1d +0.3%7d IMVT-17.8% -2.4%1d +6.3%7d NKTR-35.5% -3.7%1d +4.0%7d

Desk commentary

Authored analysis and challenge notes tied to RXRX.

1

Next earnings RXRX reports in 12 days Nov 4

Last report Aug 5

Reported the quarter ending 2026-06-30: revenue $8M, diluted EPS -$0.25, net income -$131M (SEC filing). Across the print the stock moved -3.9% (close before → first close after).

full note →

Against street estimates

How RXRX's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.

8 most recent of 11 quarters · newest report Aug 5 · projection Oct 23

Result
Aug 5 -0.23-0.25-6.8%Miss
May 6 -0.26-0.22+14.4%Beat
Feb 25 -0.32-0.21+33.3%Beat
Nov 5 '25 -0.38-0.36+5.7%Beat
Aug 5 '25 -0.35-0.41-16.0%Miss
May 5 '25 -0.52-0.50+3.1%Beat
Feb 28 '25 -0.42-0.53-27.2%Miss
Nov 6 '24 -0.33-0.34-2.1%Miss

Recent news

Headlines about RXRX from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 4 days ago · Oct 19

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

RXRX research tape

51 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.

brief The AI Trade Sold as One; Oil and Staples Took the Money scan Biotech Scan — October 16, 2026 scan Biotech Scan — October 9, 2026 brief Software and Power Took the AI Bid From the Chips; Starlink Knocked 10% Off the Carriers brief Megacaps Carry the Nasdaq to a Record While the Compute Landlords Sell
Types
Oct 16 Market Brief The AI Trade Sold as One; Oil and Staples Took the Money
AEHRAMBQAMDAMRAMZNARKWSLDESM +4 more
Oct 16 Scan Biotech Scan
IMVTBMRNENKTRINCYNVOCOGTIONSREGN +4 more
Oct 9 Scan Biotech Scan
IMVTBMRNENKTRINCYNVOCOGTIONSREGN +4 more
Oct 9 Market Brief Software and Power Took the AI Bid From the Chips; Starlink Knocked 10% Off the Carriers
AAPLACNADPTALSNAPDATRONVAXQSI +4 more
Oct 5 Market Brief Megacaps Carry the Nasdaq to a Record While the Compute Landlords Sell
ADMAMCAPAARGXAVAX-USDPCVXDNARXRX +4 more
Oct 2 Scan Biotech Scan
NKTRBMRNENVOIMVTIONSINCYALNYREGN +4 more
Sep 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 23 Scan Washout Turn Scan
AAONAEISAIAIPAMKREAOSLAPLDBKKT +4 more
Sep 18 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 17 Scan Washout Turn Scan
ACNAGIAIAVAX-USDCIFRCLSECOINDGXX +4 more
Sep 11 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 8 Scan Washout Turn Scan
AAUCADA-USDAGIALNYALTARMPAVAX-USDBITO +4 more
Sep 4 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Sep 4 Scan Washout Turn Scan
AAUCADA-USDAGIALNYALTARMPASPIAVAX-USD +4 more
Aug 31 Scan Washout Turn Scan
AAAAUCACNAIALNYARMPBAHBBAI +4 more
Aug 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 27 Scan Washout Turn Scan
AAAAUCACNADA-USDAGIAIALBALT +4 more
Aug 25 Scan Washout Turn Scan
AAAAUCACNADA-USDADBEAGIALBALT +4 more
Aug 24 Scan Washout Turn Scan
AAUCACNADA-USDADBEAGIAIALBALT +4 more
Aug 23 Scan Washout Turn Scan
AAAAUCACNADA-USDADBEAGIAIALB +4 more
Aug 22 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 22 Scan Washout Turn Scan
AAAAUCACNADA-USDADBEAGIAIALB +4 more
Aug 21 Scan Washout Turn Scan
AAAAUCACNADA-USDADBEAGIAIALB +4 more
Aug 20 Scan Washout Turn Scan
AAACNADA-USDADBEAGIAIALBAVAX-USD +4 more
Aug 19 Scan Washout Turn Scan
AAAAUCACHRACNADBEAGIAIALB +4 more
Aug 14 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 8 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Aug 5 Catalyst RXRX earnings
RXRX
Jul 31 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 28 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 25 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 17 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
Jul 11 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jul 7 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 26 Scan Biotech Scan
ABBVXBIIBBIBBQLABUMRNABIIBLLY +4 more
Jun 16 Scan Biotech Scan
ABBVGILDAMGNREGNBIIBLLYVRTXNVO +4 more
May 29 Scan Biotech Scan
AABBVALNYAMGNBEAMBIIBBMRNEBNTX +4 more
May 6 Catalyst RXRX earnings
RXRX
May 5 Catalyst RXRX earnings
RXRX
Apr 28 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCOGT +4 more
Apr 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCOGT +4 more
Apr 20 Discord $IBRX and $RXRX ?
IBRXRXRX
Mar 31 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 26 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 20 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 13 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 12 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBMRNEBNTXCRSP +4 more
Mar 11 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNEBNTX +4 more
Mar 10 Scan Biotech Scan
ABBVALNYAMGNBEAMBIIBBLUEBMRNEBNTX +4 more
Feb 2 Scan Biotech Universe
ABBVALNYAMGNBEAMBIIBBMRNEBNTXDHR +4 more